Myeloid lineage switch following CD7-targeted chimeric antigen receptor T-cell therapy in relapsed/refractory T-cell acute lymphoblastic leukemia.
Haematologica
; 108(12): 3511-3516, 2023 Dec 01.
Article
in En
| MEDLINE
| ID: mdl-37470155
Full text:
1
Database:
MEDLINE
Main subject:
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
/
Receptors, Chimeric Antigen
Limits:
Humans
Language:
En
Journal:
Haematologica
Year:
2023
Type:
Article
Affiliation country:
Canada